|
業務類別
|
Biotechnology |
|
業務概覽
|
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment. |
| 公司地址
| 1111 Dr. Frederik-Phillips Boulevard, Suite 420, Montreal, QC, CAN, H4M 2X6 |
| 電話號碼
| +1 514 336-0444 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.milestonepharma.com |
| 員工數量
| 38 |
| Mr. David I. Sandoval |
General Counsel and Chief Compliance Officer |
-- |
30/04/2026 |
| Mr. Joseph G. Oliveto |
Director, President and Chief Executive Officer |
美元 649.64K |
30/04/2026 |
| Mr. Lorenz Muller |
Chief Commercial Officer |
-- |
30/04/2026 |
| Mr. Jeffrey Edward Nelson |
Chief Operating Officer |
-- |
30/04/2026 |
| Mr. Amit Hasija |
Chief Financial Officer, Principal Accounting Officer and Executive Vice President, Corporate Development |
美元 472.77K |
30/04/2026 |
| Dr. David Bharucha, M.D.,PhD |
Chief Medical Officer |
美元 504.19K |
30/04/2026 |
|
|
| Mr. Joseph G. Oliveto |
Director, President and Chief Executive Officer |
30/04/2026 |
| Mr. Andrew R. Saik |
Independent Director |
30/04/2026 |
| Ms. Lisa M. Giles |
Independent Director |
30/04/2026 |
| Mr. Michael J. Tomsicek, M.B.A. |
Independent Director |
30/04/2026 |
| Mr. Joseph C. Papa, M.B.A.,R.Ph. |
Director |
30/04/2026 |
| Dr. Robert J. Wills, PhD |
Chairman of the Board |
30/04/2026 |
| Mr. Stuart M. Duty |
Independent Director |
30/04/2026 |
| Mr. Seth H.Z. Fischer |
Independent Director |
30/04/2026 |
|
|
|
|
